INSIGHTS ON CLINICAL TRIAL DESIGN
-
Your Biggest Unblinding Risk? Inexperienced Staff
Protect study integrity by closing the gaps in IRT workflows. Learn why rushed communication and training lapses lead to accidental unblinding and how to safeguard your clinical data.
-
Accelerate Drug Development With Master Protocols
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
Four Trends In Obesity Clinical Trials
Retention, body composition, maintenance therapy, amylin combinations, and behavioral support are reshaping obesity trials. Learn how sponsors can reduce dropout risk and strengthen clinical data.
-
RTSM Automating Adaptive Enrollment In Basket Trials
Adaptive basket trials need real-time data to close underperforming cohorts fast. See how automation closes that gap and protects patients.
-
Breaking The Trial Bottleneck: Smarter, Faster Paths To Patients7/10/2026
AI is speeding clinical trials — but silos and complexity persist. Discover how connected systems and automation can enable faster, more adaptive development.
-
The Role Of Oncology Biomarkers In Personalizing Hematology Treatment Plans6/18/2026
Oncology biomarkers guide personalized treatment and help track disease changes. Learn more about how advancements like liquid biopsies improve precision care.
-
A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data2/25/2025
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
-
Building the Blueprint: What Psychedelic Trials Need Now7/29/2026
Discover how leading experts are addressing recent regulatory reviews to shape the next phase of psychedelic clinical research.
-
Harness An Adept IRB's Expertise To Streamline Study Design10/2/2026
An Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.
-
Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
-
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.
-
Support proof-of-concept trials with integrated clinical and CRO capabilities spanning study design, site selection, patient recruitment, monitoring, and data delivery.
-
Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.